AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30261902
Drug: Combination ART
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination ART
Trial: 29608685
Drug: Dolutegravir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir monotherapy
Trial: 22156542
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) at 67 μg/kg/day
Trial: 22156542
Drug: Untreated control
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated control (UC) group at 33 μg/kg/day
Trial: 9891195
Drug: Other laxatives
RxNorm normalized name: LAXATIVES,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other laxatives (mainly lactulose)
Trial: 8022533
Drug: 100 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 micrograms triiodothyronine (T3) administered orally for 3 consecutive days
Trial: 1079213
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg daily
Trial: 1096901
Drug: Indometacin 100
RxNorm normalized name: Indometacin 100 mg rectal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indometacin 100 mg daily
Trial: 12500022
Drug: Micronized fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized fenofibrate (200 mg once daily)
Trial: 8380266
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 4 mg, 4 times daily for 8 weeks
Trial: 3298387
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration of bovine superoxide dismutase (SOD) at a dosage of 0.25 mg/kg
Trial: 24957950
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination (Vaxigrip)
Trial: 20540666
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g daily EPA
Trial: 20540666
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g daily DHA
Trial: 10854812
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg orally, qds for 10 days
Trial: 30117300
Drug: Moxidectin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxidectin (4 mg, 8 mg, 16 mg, 24 mg, or 36 mg)
Trial: 27258494
Drug: Long-term dual
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term dual antiplatelet therapy (DAT) (>12 months)
Trial: 27258494
Drug: Short-term dual
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term dual antiplatelet therapy (DAT) (<12 months)
Trial: 27258494
Drug: Clopidogrel therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel therapy for >12 months
Trial: 12852712
Drug: IV linezolid
RxNorm normalized name: Linezolid
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV linezolid 600 mg every 12 hours for 7 to 21 days
Trial: 12852712
Drug: IV vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV vancomycin 1 g every 12 hours for 7 to 21 days
Trial: 8853535
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality therapy (radiation and chemotherapy)
Trial: 3909471
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 500 mg + codeine phosphate 30 mg
Trial: 6373441
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 500 mg
Trial: 27255456
Drug: Hydroalcoholic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroalcoholic extract of Tribulus terrestris (1000 mg/d)
Trial: 22789657
Drug: Online cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online cognitive behavior therapy (CBT) with minimal therapist contact
Trial: 18947350
Drug: Comparative judgments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparative judgments (e.g., indicating preference between two stimuli in different domains, comparing wild animals, comparing animals' physical attributes, estimating similarity between objects)
Trial: 7674270
Drug: First-line combination
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line combination therapy
Trial: 23611083
Drug: TMT root
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMT root treatment
Trial: 21936251
Drug: Probiotic yoghurt
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic yoghurt (200 g daily containing Lactobacillus acidophilus La5 and Bifidobacterium animalis BB12, 10(7) CFU g(‐1) for each)
Trial: 2227611
Drug: Estriol 4
RxNorm normalized name: ESTRIOL 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol 4 mg once daily
Trial: 31578015
Drug: Nadroparin 1,900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadroparin 1,900 IU (0.2 mL) intravenously (IV group)
Trial: 31578015
Drug: Nadroparin 3,800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadroparin 3,800 IU (0.4 mL) subcutaneously (SC group)
Trial: 20719303
Drug: Low-dose endotoxin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose endotoxin
Trial: 25315260
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day ALN
Trial: 21817116
Drug: Intraperitoneal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal administration of baicalein by repeated injection
Trial: 19657202
Drug: AFA breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AFA breathing therapy
Trial: 14976885
Drug: Integrative Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrative Chinese and Western medicine (ICWM) therapeutic program
Trial: 9024142
Drug: Daily drinkers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily drinkers (>= 7 drinks per week)
Trial: 8329004
Drug: L-glutamine monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-glutamine monofluorophosphate (G-MFP) tablets
Trial: 8329004
Drug: L-glutamine monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-glutamine monofluorophosphate (G-MFP) powder for oral use
Trial: 16281491
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg + aspirin 325 mg (group 1)
Trial: 16281491
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg + aspirin 325 mg (group 2)
Trial: 10464060
Drug: L-NMMA (13.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (13.5 mg/kg)
Trial: 10464060
Drug: NO inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NO inhalation (30 p.p.m)
Trial: 19890262
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (placebo)
Trial: 8751032
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg q.i.d. for 6 days)
Trial: 631030
Drug: Hydergine (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydergine (4.5 mg daily)
Trial: 23985625
Drug: Peramivir 600
RxNorm normalized name: peramivir 600 mg in 60 mL INTRAVENOUS SOLUTION [Rapivab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peramivir 600 mg once daily
Trial: 20613645
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CON) performing only technical preparation.
Trial: 18410584
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg melatonin (n = 24)
Trial: 12000008
Drug: Pentoxifylline (Ptx)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (Ptx) 500 mg l(‐1) added to prime solution
Trial: 12000008
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received only prime solution
Trial: 8670316
Drug: rHuIL‐1Ra 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuIL‐1Ra 20 mg administered once, 3 times, or 7 times per week
Trial: 8670316
Drug: rHuIL‐1Ra 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuIL‐1Ra 70 mg administered once, 3 times, or 7 times per week
Trial: 8670316
Drug: rHuIL‐1Ra 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuIL‐1Ra 200 mg administered once, 3 times, or 7 times per week
Trial: 19934090
Drug: Haemoglobin (Hb)
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemoglobin (Hb) of 9-10 g/dl
Trial: 19934090
Drug: Haemoglobin (Hb)
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemoglobin (Hb) > 13 g/dl
Trial: 15860488
Drug: Paclitaxel 35
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 35 mg/m2/24 h continuously infused over 96 h (days 1-4) every 21 days for up to six courses
Trial: 10076743
Drug: Cognitive-behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behaviour therapy (CBT) and medication simultaneously (n = 9)
Trial: 10076743
Drug: Cognitive-behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behaviour therapy (CBT) only (n = 6)
Trial: 10076743
Drug: Medication while
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication while on a wait-list for CBT (n = 6)
Trial: 10076743
Drug: Subsequent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subsequent administration of CBT to those groups on the wait-list
Trial: 9395604
Drug: High-density negative
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-density negative ion treatment (2.7 x 10(6) ions/cm3)
Trial: 9395604
Drug: Low-density negative
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-density negative ion treatment (1 x 10(4) ions/cm3)
Trial: 1954643
Drug: Slow-K tablets
RxNorm normalized name: Slow-Fe
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Slow-K tablets
Trial: 30223315
Drug: Intraperitoneal dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraperitoneal dexamethasone 8 mg (IP)
Trial: 9292561
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous dose of 750 mg of vancomycin administered 6 to 12 hours before the procedure
Trial: 17707753
Drug: Adjuvanted vaccine
RxNorm normalized name: PIKA-adjuvanted vaccine composition
DrugBank: PIKA rabies vaccine (DB17963)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted vaccine (3.8 microg)
Trial: 17707753
Drug: Adjuvanted vaccines
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted vaccines (all doses)
Trial: 17707753
Drug: Non-adjuvanted vaccines
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjuvanted vaccines (all doses)
Trial: 10973155
Drug: All vaccine
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All vaccine formulations
Trial: 22381809
Drug: Tacrolimus monotherapy
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus monotherapy
Trial: 11589769
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (CAP)
Trial: 8201130
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light for 1 h daily for 2 weeks
Trial: 21199175
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg intravenously)
Trial: 23530729
Drug: Prostaglandin E₂
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin E₂ gel
Trial: 20419525
Drug: Olanzapine for
RxNorm normalized name: Olanzapine for Extended-Release Injectable Suspension
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine for adjunctive treatment of anorexia nervosa
Trial: 16909188
Drug: Oral trimethoprim
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral trimethoprim (TMP) 5 mg/kg
Trial: 16909188
Drug: Oral trimethoprim
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral trimethoprim (TMP) 10 mg/kg
Trial: 16909188
Drug: Oral trimethoprim
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral trimethoprim (TMP) 20 mg/kg
Trial: 16909188
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of oral TMP 5 mg/kg
Trial: 16909188
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of oral TMP 10 mg/kg
Trial: 15072506
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg/day (n = 15)
Trial: 1568369
Drug: Metadoxine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metadoxine (500 mg twice a day)
Trial: 11870439
Drug: Standard-dose FDT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose FDT (S400, n=25)
Trial: 19508679
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg rhTSH
Trial: 7909705
Drug: Felodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (5 mg) plus Metoprolol (50 mg)
Trial: 7909705
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg) plus Atenolol (50 mg)
Trial: 3781700
Drug: Ambroxol (1.5‐2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol (1.5‐2.0 mg/kg body weight orally)
Trial: 25338443
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment group
Trial: 28629344
Drug: ONO-5334 100
RxNorm normalized name: ONO-5334
DrugBank: ONO-5334 (DB19206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-5334 100 mg QD
Trial: 24038152
Drug: ONO-5334 300
RxNorm normalized name: ONO-5334
DrugBank: ONO-5334 (DB19206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-5334 300 mg QD
Trial: 28629344
Drug: ONO-5334 50
RxNorm normalized name: ONO-5334
DrugBank: ONO-5334 (DB19206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-5334 50 mg BID
Trial: 28629344
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of ONO-5334 50 mg BID vs. 100 mg QD
Trial: 11081529
Drug: Post-treatment isoniazid
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment isoniazid prophylaxis
Trial: 1588829
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/d and 40 mg/d)
Trial: 1588829
Drug: Fenofibrate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (400 mg/d)
Trial: 3014473
Drug: Oka-strain live
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain Injection [Varivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oka-strain live varicella vaccine
Trial: 29224964
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of combined MMR and one dose of monovalent varicella vaccine (MMR+V)
Trial: 2108474
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose pion irradiation (total doses from 2720-3420 cGy, fraction sizes from 170 to 205 cGy, treatment times from 4 to 5 weeks)
Trial: 2108474
Drug: Accelerated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated treatment with 3280 cGy in 14-22 days
Trial: 29542390
Drug: Omega-3 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 (300 mg daily, 180 mg EPA and 120 mg DHA)
Trial: 29542390
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (200 IU daily)
Trial: 27935240
Drug: liraglutide 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide 1.8 mg once daily
Trial: 21400790
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists and hydroxyethyl starch solution (130/0.4)
Trial: 28821284
Drug: 12-week combined
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week combined aerobic and resistance exercise program supervised by a physiotherapist, plus daily physical activity of at least 30 minutes
Trial: 12661246
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy
Trial: 8020525
Drug: iomeprol-350 (350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iomeprol-350 (350 mgI/ml)
Trial: 8020525
Drug: iopamidol-370 (370
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iopamidol-370 (370 mgI/ml)
Trial: 8020525
Drug: iomeprol-400 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iomeprol-400 (400 mgI/ml)
Trial: 2690305
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 vaginal gel (first dose: 1 mg, second dose 1 or 2 mg, six hours later)
Trial: 2690305
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 vaginal gel
Trial: 25168164
Drug: Stepwise addition
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepwise addition (SWA) of bolus insulin aspart
Trial: 25168164
Drug: Full basal-bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full basal-bolus (FBB) therapy
Trial: 15977084
Drug: Antimigraine drugs
RxNorm normalized name: Corticosteroid derivatives, antimigraine drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimigraine drugs
Trial: 7702137
Drug: Blind oral
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind oral intubation
Trial: 2746493
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose lorazepam (0.0225 mg/kg)
Trial: 1308305
Drug: Diazepam (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.15 mg/kg)
Trial: 31371228
Drug: Adjuvant hyperthermic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) followed by routine adjuvant systemic chemotherapy
Trial: 30911659
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy only
Trial: 23172931
Drug: AM dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM dose (once-daily antihypertensive medications taken in the morning)
Trial: 23172931
Drug: PM dose
RxNorm normalized name: Allergy AM-PM Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PM dose (once-daily antihypertensives taken at bedtime)
Trial: 23172931
Drug: Add-on dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Add-on dose (once-daily antihypertensives taken in the morning and an additional antihypertensive medication before bedtime)
Trial: 21816199
Drug: 15 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 μg VLP vaccine
Trial: 21816199
Drug: 45 μg
RxNorm normalized name: tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 45 μg VLP vaccine
Trial: 16690579
Drug: Self-report of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-report of daily living skills using the Health Assessment Questionnaire (HAQ)
Trial: 11550740
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment (BT)
Trial: 20025554
Drug: Voglibose (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose (0.9 mg daily)